79372347 - COMBI-OGAB

Information

• Trademark
• 79372347

• Source

• Serial Number

  79372347

• Registration Number

  7394363

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 31, 2023
  a year ago

• Registration Date

  May 28, 2024
  8 months ago

• Transaction Date

  June 27, 2024
  7 months ago

• Status Date

  May 28, 2024
  8 months ago

• Published for Opposition Date

  March 12, 2024
  10 months ago

• Location Date

  May 27, 2024
  8 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  SWIFT, GILBERT M

• Law Office Assigned Location Code

  L90

• Owners

  • SYNPLOGEN CO., LTD

Case File Statements

• GS0421: Research and development relating to DNA synthesis technology; technical advisory services relating to DNA synthesis technology; research and development relating to production and analysis of virus vector; technological advisory services relating to production and analysis of virus vector; research and development relating to production and analysis of mRNA; technological advisory services relating to production and analysis of mRNA; research and development relating to gene therapy; technical advisory services relating to gene therapy research; technological advisory services relating to productization of gene therapy products; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, and technical advisory services relating thereto in the fields of protein, antibody, vaccine, virus, virus vector, mRNA, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services relating to genome synthesis technology; research and development, and technical advisory services relating thereto in the fields of protein, vaccine, virus, virus vector, mRNA, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection, and research of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; quality testing, inspection, and research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; research and development relating to production and analysis of virus vector for others; research and development relating to gene therapy products for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; quality testing, inspection, and research in the fields of agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; research and development in the field of gene expression systems; research and development in the fields of microorganisms and cells; research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; bacteriological research; biological research

Case File Event Statements

• 6/23/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/27/2023 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/22/2023 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 12/27/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 2/21/2024 - 11 months ago

  8 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/21/2024 - 11 months ago

  6 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 2/21/2024 - 11 months ago

  7 - NOTICE OF PUBLICATION Type: NPUB

• 3/12/2024 - 10 months ago

  9 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/1/2024 - 12 months ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/12/2024 - 10 months ago

  10 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/28/2024 - 8 months ago

  11 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/27/2024 - 7 months ago

  12 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR